CIITA
(Class II, Major Histocompatibility Complex, Transactivator (CIITA))
宿主
人, 小鼠
资源
合成
应用范围
Blocking Peptide (BP), Western Blotting (WB)
产品特性
This is a synthetic peptide designed for use in combination with anti-C2TA antibody (Catalog #: ARP36830_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
限制
仅限研究用
状态
Lyophilized
溶解方式
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
浓度
1 mg/mL
缓冲液
Final peptide concentration is 1 mg/mL in PBS.
注意事项
Avoid repeated freeze-thaw cycles.
储存条件
-20 °C
储存方法
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
抗原
CIITA
(Class II, Major Histocompatibility Complex, Transactivator (CIITA))
别名
CIITA Peptide, C2ta Peptide, EG669998 Peptide, Gm9475 Peptide, C2TA Peptide, CIITAIV Peptide, MHC2TA Peptide, NLRA Peptide, Mhc2ta Peptide, class II, major histocompatibility complex, transactivator Peptide, class II major histocompatibility complex transactivator Peptide, MHC class II transactivator Peptide, class II transactivator Peptide, CIITA Peptide, LOC710761 Peptide, ciita Peptide, LOC100443575 Peptide, Ciita Peptide, LOC100736732 Peptide
背景
C2ta is essential for transcriptional activity of the HLA class II promoter, activation is via the proximal promoter. No DNA binding of in vitro translated CIITA was detected. C2ta may act in a coactivator-like fashion through protein-protein interactions by contacting factors binding to the proximal MHC class II promoter, to elements of the transcription machinery, or both. Alternatively it may activate HLA class II transcription by modifying proteins that bind to the MHC class II promoter